Results 161 to 170 of about 7,977,848 (398)
Funding the Future: Resources for Adolescent Reproductive and Sexual Health Programs in Developing Countries [PDF]
Provides a directory of over 90 foundations, agencies, and organizations that support adolescent reproductive and sexual health related programs in developing countries, through direct and/or indirect financing, technical assistance, and ...
Kent Klindera, Scott M. Painter
core
Health Care and its Financing in Italy: Issues and Reform Options [PDF]
Franco Reviglio
openalex +3 more sources
The impact of COVID-19 on health financing in Kenya. [PDF]
Kairu A+9 more
europepmc +2 more sources
This study simultaneously investigated circulating tumor cells (CTCs) and exosomes from small‐cell lung cancer (SCLC) patients. The elevated expression of JUNB and CXCR4 in CTCs was a poor prognostic factor for SCLC patients, whereas exosomal overexpression of these biomarkers revealed a high discrimination ability of patients from healthy individuals,
Dimitrios Papakonstantinou+13 more
wiley +1 more source
Analysis of ESR1 mutations in plasma cell‐free DNA (cfDNA) is highly important for the selection of treatment in patients with breast cancer. Using multiplex‐ddPCR and identical blood draws, we investigated whether circulating tumor cells (CTCs) and cfDNA provide similar or complementary information for ESR1 mutations.
Stavroula Smilkou+11 more
wiley +1 more source
Distributive Injustice(s) in American Health Care [PDF]
Havighurst and Richman seek to show the nature--and to suggest the cumulative attitude--of the many regressive tendencies of the financing, regulatory and legal regime governing the private side of US health ...
Havighurst, Clark C., Richman, Barak D.
core +2 more sources
Economic Issues in Reform of Health Care Financing [PDF]
Henry J. Aaron+3 more
openalex +1 more source
Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer
mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor
Khrystany T. Isebia+17 more
wiley +1 more source